前言对血栓症的治疗,大致可分为抗凝血疗法和纤溶疗法。纤溶疗法已往是以溶解血栓为治疗的主要目的。抗凝血疗法最近受到重视,给予具有抑制血小板凝集作用的药物,可预防血栓症的发生,这就是抗血小板疗法。血栓症的发生主要原因是由于血小板凝集功能亢进引起的,这时血小板的血栓烷A_2合成的功能是亢进的。实践证明,在心肌梗塞刚发病后,糖尿病、 Preface The treatment of thrombosis can be divided into anticoagulant therapy and fibrinolysis. Fibrinolytic therapy has historically been the primary goal of thrombolytic therapy. Recently, attention has been given to anticoagulant therapy, and administration of drugs that inhibit platelet aggregation can prevent thrombosis. This is antiplatelet therapy. The main reason for the occurrence of thrombosis is due to hyperthyroidism caused by platelet aggregation, when platelet thromboxane A_2 synthesis is hyperthyroidism. Practice has proved that just after the onset of myocardial infarction, diabetes,